Clinical trial · Interventional
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Addressing Disparities in Breast Cancer Care: An Approach to Health Equity
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Carcinoma | Breast Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Breast Ductal Carcinoma in Situ | Breast Ductal Carcinoma In Situ | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient Navigation | Behavioral | — | UNRESOLVED |
| Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Health Services Research (Patient Navigation)
- description
- Patients receive patient navigation services from a patient navigator as needed to improve knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance skills related to management of cancer treatment
- interventionNames
- Behavioral: Patient Navigation
- Other: Questionnaire
Primary outcomes (4)
- measure
- Enrollment rate
- timeFrame
- Up to 2 years
- description
- Enrollment rate Will be defined as the number of patients enrolled divided by the number of patients approached. The enrollment rate will be estimated with a 90% credible region obtained by Jeffrey's prior method.
- measure
- Reasons for refusal
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years of age * Have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS) * Currently identify their gender as woman or female * Was assigned female sex at birth (AFAB) \- Participant is experiencing ≥1 barrier to care as determined by the social needs screening tool * Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention Exclusion Criteria: * Participants who are not suspected of or diagnosed with breast cancer or Ductal Carcinoma in Situ (DCIS) * Participants who have had a previous diagnosis of any cancer * Participants who were assigned male sex or intersex at birth * Unwilling or unable to follow protocol requirements
References
Publications (0)
Data not yet available